iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Up 621.1% in July

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 8,033 shares, an increase of 621.1% from the July 15th total of 1,114 shares. Currently, 2.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,025 shares, the short-interest ratio is presently 7.8 days.

iShares Health Innovation Active ETF Stock Performance

iShares Health Innovation Active ETF stock remained flat at $32.33 during mid-day trading on Wednesday. The company’s stock had a trading volume of 966 shares, compared to its average volume of 3,500. The firm’s 50 day simple moving average is $30.21 and its two-hundred day simple moving average is $29.62. iShares Health Innovation Active ETF has a 12-month low of $24.96 and a 12-month high of $32.35. The company has a market cap of $11.64 million, a price-to-earnings ratio of 24.91 and a beta of 0.73.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in iShares Health Innovation Active ETF stock. Comprehensive Financial Planning Inc. PA purchased a new stake in iShares Health Innovation Active ETF (NYSEARCA:BMED) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 10,832 shares of the company’s stock, valued at approximately $309,000. Comprehensive Financial Planning Inc. PA owned approximately 3.01% of iShares Health Innovation Active ETF as of its most recent SEC filing.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.